Top 50 Medical VC (Venture Capital) Funds in United Kingdom in September 2025
A list of 50 VC (Venture Capital) funds that invest in Medical startups based in United kingdom. We rank investors based on the number of investments they made in Medical companies from United kingdom. We update this investor list every month.Top 50 Medical VC (Venture Capital) Funds in United Kingdom in September 2025
Parkwalk is a London-based fund management firm. Parkwalk invests in UK technology companies that have IP backing and freedom to operate, generally spun out of UK universities. Their funds seek to generate capital gains for their investors, enhanced by the attractive tax relief provided by EIS. Parkwalk entered this investment sector in 2009,anticipating a wave of tax-efficient incentives launched by the UK Government to stimulate innovative emerging technology companies and thereby help drive economic growth.Parkwalk utilises academic, technology transfer, venture capital and personal networks developed over many years to gain access to the highest calibre deal-flow. In 2017 Parkwalk joined forces with IP Group plc, a leading intellectual property commercialisation company that is listed on the Main Market of the London Stock Exchange under the ticker symbol IPO. As at March 2019 the combined group has net assets of £1.2bn.
Show more
Investment focus
- Biotechnology, Health Care, Software
- Seed, Series A, Series B
- United Kingdom, United States, Philippines
Portfolio highlights
- Brainomix — Since launching as a spin-out from the University of Oxford in 2010, Brainomix has developed award-winning, AI-powered imaging biomarkers, assisting physicians across the world to make better life-saving decisions. Brainomix seminal product, e-Stroke is a collection of tools that use state-of-the-art AI algorithms to support doctors by providingreal-time interpretation of brain scans to help guide treatment and transfer decisions for stroke patients, allowing more patients to get the right treatment, in the right place, at the right time.
- Ceryx Medical — Ceryx Medical Ltd are the revolutionary business behind a unique bioelectronic technology that could change the way diseases such as heart failure are treated.
- Enhanc3D Genomics — Enhanc3D Genomics is a spinout company from Babraham Institute.
Deepbridge is a different kind of investment manager. They work closely with financial advisers and investors to design innovative products, ranging from investment in technology growth companies to asset-backed renewable energy projects. They also partner with innovative and committed management teams to help UK based companies realise theirpotential and become successful leading-edge businesses.
Show more
Investment focus
- Health Care, Biotechnology, Medical
- Seed, Funding Round, Series A
- United Kingdom, Australia, Singapore
Portfolio highlights
- AI-Sight — AI-Sight is a startup that is developing an AI diabetic retinal screening system to deliver WHO-recommended diabetic eye screening services.
- upLYFT — upLYFT is working on the next generation of smart wearables to help with musculoskeletal issues related to aging. Also working with pro athletes to help sporting individuals train harder and break records.
- Spotlight Pathology — Spotlight Pathology develops decision support tools powered by artificial intelligence (AI) to help in the diagnosis of blood cancers.
UKI2S, formally the Rainbow Seed Fund, is an investment fund backed by the government, providing seed funding to science & technology start-ups and SMEs
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Seed, Funding Round, Series A
- United Kingdom, United States
Portfolio highlights
- Messium — Messium's technology makes use of proprietary machine learning models and hyperspectral satellite constellations.
- Spaceflux — As satellites become increasingly vital, Spaceflux tackles the growing challenges of orbital congestion and debris that put them at risk. Thanks to our proprietary global network of optical sensors, we provide data-driven space situational awareness services from LEO to Cislunar.
- Myosin Therapeutics — Myosin Therapeutics is a privately-held biopharmaceutical company developing novel medications targeting cellular motor proteins.
Oxford Science Enterprises is the university-partnered venture firm. We work with the University of Oxford to build companies that create fundamental technologies: science-based businesses capable of tackling the planet’s toughest problems. We invest in life science, AI and software, healthcare, and deep tech to create companies taking onchallenges like nuclear fusion, quantum computing and developing treatments and cures for infectious diseases. Founded in 2015, we’ve raised over £600M to create a world-class technology ecosystem, and combine our deep experience with a network of investors, entrepreneurs and sector-experts to find co-investment, build businesses, and hire senior management talent.
Show more
Investment focus
- Health Care, Biotechnology, Software
- Seed, Series A, Series B
- United Kingdom, United States, Finland
Portfolio highlights
- FluoRok — By employing our patented technology, we can produce fluorochemicals without the production of toxic and highly dangerous hydrofluoric acid
- Neu Health — Neu Health enables clinicians, care givers and patients to tackle this growing challenge with cutting-edge digital technologies designed to make the latest care accessible for all, improving outcomes today and accelerating future breakthroughs.
- Salience Labs — Salience Labs is building a hybrid photonic-electronic chip for AI. We have designed a massively parallel, ultra-high-throughput Photonic Tensor Processing Unit. Photonics allows data to be modulated at up to 100 GHZ, and allows for high levels of parallelization using multiplexing. We integrate this photonic unit into a SoC architecture designedto exploit its high throughput for AI inference. Salience Labs technology is based on decades of research collaboration between Oxford University and the University of Münster, Germany.
Scotland's business advice, support and funding agency. Explore our products and services to find the right support for your business and apply online today.
Show more
Investment focus
- Biotechnology, Software, Health Care
- Seed, Grant, Funding Round
- United Kingdom, United States, Japan
Portfolio highlights
- Swurf — The work surfing platform. Making it easy for venues to welcome a new community of remote workers.
- Gigged.AI — Get AI-powered, real-time visibility over your tech team capabilities to power internal mobility. Fill skill gaps with ease using our on-demand talent network.
- Bright Ascension — Bright Ascension offers mission ready software in space and on the ground. Our integrated software is perfect for any satellite mission.
Oxford Technology's SEIS fund and EIS fund enable private investors to access high growth technology startup opportunities and support UK innovation. SEIS and EIS tax reliefs offer downside protection, whilst gains can be tax free.
Show more
Investment focus
- Biotechnology, Health Care, Software
- Seed, Funding Round, Series A
- United Kingdom, United States
Portfolio highlights
- OxCan — Enabling curative cancer treatment through early detection
- CryoLogyx — Assay Ready Cells - Discover CryoLogyx's advanced cryopreservation solutions, optimized for cell-based assays in drug discovery. Simply thaw with cell culture medium, and they are ready for use within 24 hours post-thaw.
- Metacarpal — Metacarpal design upper-limb prosthetics without compromise. We aim to make the most robust, functional hand prosthesis that people love wearing because it works so effectively and looks so beautiful. Be proud to show your artificial side!
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates.
HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more
Investment focus
- Biotechnology, Health Care, Software
- Seed, Convertible Note, Pre-Seed
- United States, India, United Kingdom
Portfolio highlights
- MixRift — MIXRIFT - game developers specialized in Mixed Reality
- unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
- Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
Established in 1992. Archangels is the oldest continuously operating business angel syndicate in the World. Investing in IP-rich tech & life sciences companies in Scotland, UK.
Show more
Investment focus
- Software, Biotechnology, Health Care
- Funding Round, Seed, Series A
- United Kingdom, United States
Portfolio highlights
- CSignum — Revolutionising underwater communications with electromagnetic technology for seamless data integration between surface & submerged devices.
- Administrate — Administrate is a comprehensive, configurable training management platform that helps organizations streamline enterprise learning and development. Organize, deliver, plan, automate, analyze, and scale your training program effectively -- all through one system. Deliver multi-modality learner experiences, maximize training resources, anddemonstrate business results with insight-rich reporting. Hundreds of organizations serving millions of learners choose Administrate to manage their training program.
- iGii — Integrated Graphene enable better products with a revolutionary design for manufacture process producing the world's highest quality pure 3D Graphene Foam, Gii.
Oxford Science Enterprises is the university-partnered venture firm. We work with the University of Oxford to build companies that create fundamental technologies: science-based businesses capable of tackling the planet’s toughest problems. We invest in life science, AI and software, healthcare, and deep tech to create companies taking onchallenges like nuclear fusion, quantum computing and developing treatments and cures for infectious diseases. Founded in 2015, we’ve raised over £600M to create a world-class technology ecosystem, and combine our deep experience with a network of investors, entrepreneurs and sector-experts to find co-investment, build businesses, and hire senior management talent.
Show more
Investment focus
- Health Care, Biotechnology, Software
- Series A, Seed, Series B
- United Kingdom, United States, The Netherlands
Portfolio highlights
- FluoRok — By employing our patented technology, we can produce fluorochemicals without the production of toxic and highly dangerous hydrofluoric acid
- Neu Health — Neu Health enables clinicians, care givers and patients to tackle this growing challenge with cutting-edge digital technologies designed to make the latest care accessible for all, improving outcomes today and accelerating future breakthroughs.
- Salience Labs — Salience Labs is building a hybrid photonic-electronic chip for AI. We have designed a massively parallel, ultra-high-throughput Photonic Tensor Processing Unit. Photonics allows data to be modulated at up to 100 GHZ, and allows for high levels of parallelization using multiplexing. We integrate this photonic unit into a SoC architecture designedto exploit its high throughput for AI inference. Salience Labs technology is based on decades of research collaboration between Oxford University and the University of Münster, Germany.
Speak with our Entrepreneurship and Investment teams, who can help you find sources of finance, engage with funders and secure investment to grow your business.
Show more
Investment focus
- Software, Biotechnology, Health Care
- Funding Round, Seed, Series A
- United Kingdom, United States, France
Portfolio highlights
- Bio-Images Drug Delivery — BDD Pharma combine drug delivery expertise and clinical capabilities to accelerate product development pipelines, enable life cycle management and new innovative pharmaceutical products. Rapid parallel clinical testing with SWIFT significantly reduces time from product concept to clinical success.
- IOTech — Discover IOTech Systems, the open edge data platform for developing, deploying, and managing Industrial Edge applications at scale. Find out more here.
- Administrate — Administrate is a comprehensive, configurable training management platform that helps organizations streamline enterprise learning and development. Organize, deliver, plan, automate, analyze, and scale your training program effectively -- all through one system. Deliver multi-modality learner experiences, maximize training resources, anddemonstrate business results with insight-rich reporting. Hundreds of organizations serving millions of learners choose Administrate to manage their training program.
Mercia Asset Management provides equity and debt to UK businesses with growth ambition. We are your investment partners from scale-up to exit.
Show more
Investment focus
- Software, Health Care, Biotechnology
- Seed, Funding Round, Series A
- United Kingdom, United States, Hungary
Portfolio highlights
- Administrate — Administrate is a comprehensive, configurable training management platform that helps organizations streamline enterprise learning and development. Organize, deliver, plan, automate, analyze, and scale your training program effectively -- all through one system. Deliver multi-modality learner experiences, maximize training resources, anddemonstrate business results with insight-rich reporting. Hundreds of organizations serving millions of learners choose Administrate to manage their training program.
- Warwick Acoustics — Warwick Acoustics believe in creating products that are designed from the ground up in order to deliver the best personal audio listening experience available to customers.
- Melius Cyber — Melius Cyber continuously monitors an organization's IT network, testing security and protecting it from the latest threats.
The GM&C Life Sciences Fund is a seed and early stage venture capital fund targeting life sciences businesses located in the Greater Manchester and Cheshire & Warrington region. The Fund is managed by Catapult Venture Managers ("Catapult Ventures").The Fund is based at Alderley Park, which is well recognised as a site ofnational importance, being the largest life sciences campus of its kind in the UK with more than 500,000 sq. ft. of top-end laboratory and related space and facilities. Until recently, the Park was the R&D headquarters for AstraZeneca.Since 2002, Catapult Ventures has backed a significant number of companies across a broad range of life sciences, including therapeutics (such as Abzena and Oxford BioTherapeutics), medical devices (such as Monica Healthcare and Probe Scientific), contract research organisations (such as R5 Pharmaceuticals and FDAS), diagnostics developers (such as Lumora and Biofortuna), as well as developers of technology used in healthcare applications (such as Oxford Cryosystems and Accutronics). The Fund is the result of a collaboration between Cheshire and Warrington Enterprise Partnership, Greater Manchester Combined Authority, Cheshire East Council, and Manchester Science Partnerships.
Show more
Investment focus
- Health Care, Biotechnology, Medical
- Seed, Funding Round, Series A
- United Kingdom, Italy, Germany
Portfolio highlights
- ScubaTx — ScubaTx is a breakthrough organ preservation device organ transplant. The ScubaTx device will leverage world-leading expertise in software design to commercialise a proven but unexploited organ preservation technique, Persufflation. ScubaTx will offer healthcare providers significant net savings, an
- Flynotes — Flynotes is a digital software platform helping dentists deliver personalised patient care
- QV Bioelectronics — Manchester-based start-up QV Bioelectronics is developing innovative electrotherapy devices for the treatment of certain types of brain tumours.
As a team, we have a passion for science and its potential to drive change. Through our expertise and our position in one of the country's most powerful science and technology ecosystems, we're able to identify and support the most promising entrepreneurs in knowledge intensive businesses and help them achieve their vision.With our financial backing and expert guidance, we're excited to enable the pioneers in life sciences and deep tech to create world-leading companies whose unique ideas bring financial success and global impact.
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series A, Series B, Seed
- United Kingdom, United States, Ireland
Portfolio highlights
- Sortera Bio — Sortera Bio operates as a biotechnology company. Sortera is committed to providing revolutionary solutions in biologics discovery.
- Salience Labs — Salience Labs is building a hybrid photonic-electronic chip for AI. We have designed a massively parallel, ultra-high-throughput Photonic Tensor Processing Unit. Photonics allows data to be modulated at up to 100 GHZ, and allows for high levels of parallelization using multiplexing. We integrate this photonic unit into a SoC architecture designedto exploit its high throughput for AI inference. Salience Labs technology is based on decades of research collaboration between Oxford University and the University of Münster, Germany.
- TRIMTECH Therapeutics — Transformative treatments for CNS and inflammatory disorders by selectively destroying disease-causing protein aggregates
Northstar Ventures invests venture capital in early and later stage, high growth companies tackling global challenges, focusing on climate tech and healthy ageing.
Show more
Investment focus
- Software, Health Care, E-Commerce
- Seed, Funding Round, Series A
- United Kingdom, United States, Indonesia
Portfolio highlights
- Nanovery — Founded by scientists specialised in Nanotechnology, Medicinal Chemistry and Artificial Intelligence, we are on a mission to enable early detection of cancer through a rapid and affordable blood test Backed by academics at top universities, clinicians, industrial leaders, and Entrepreneur First.
- AI Hay — AI Hay develops an AI-driven answer engine that allows users to access information through a question-and-answer format. The company combines hyperlocal, culturally nuanced knowledge discovery engines with social loops to enhance community validation and perspectives. It utilizes in-house specialized large-language models, retrieval-augmentedgeneration (RAG), and social features to build a knowledge discovery platform that serves the community.
- Magnitude Biosciences — Magnitude Biosciences is a biotechnology firm combine experience in ageing research, the nematode C. elegans and automation.
Development Bank of Wales is an independent company, providing commercial funding to Welsh SMEs. They invests private and public funds, including EU funds.
Show more
Investment focus
- Software, Health Care, Biotechnology
- Seed, Funding Round, Debt Financing
- United Kingdom, Australia, United States
Portfolio highlights
- nisien.ai — Nisien.ai uses industry-leading AI for the detection, defence and resolution of online harm, for better online safety and digital wellbeing.
- Ceryx Medical — Ceryx Medical Ltd are the revolutionary business behind a unique bioelectronic technology that could change the way diseases such as heart failure are treated.
- Lumin Solutions — Making care recording simpler, safer & child-focused for UK youth care providers. MyLifePlan helps you save time, ensure compliance & deliver outstanding care. Discover how!
The team behind Catapult Ventures are among the most experienced venture capital investors in the UK.Their experience spans a range of sectors from healthcare and pharmaceuticals to luxury consumer brands, manufacturing and software, as well as all stages: from start-ups and pre-revenue IP developers to company floatation and billions of poundsin revenue. Their administration team is equally experienced with each member having more than 10 years experience in a venture capital environment.
Show more
Investment focus
- Health Care, Biotechnology, Medical
- Funding Round, Seed, Series A
- United Kingdom, United States, Israel
Portfolio highlights
- Path Robotics — We create manufacturing robots that autonomously scan, position, and weld your parts without the need for skilled welders or robot programmers.
- Pickle Robot — We make robots that unload trucks without retrofitting the warehouse
- Anello Photonics — Anello Photonics is founded by pioneers in silicon photonics and inertial navigation. The patented Anello SiPhOG gyroscope offers an affordable mass-market sensor with true Optical Gyroscope performance. The company is headquartered in Silicon Valley and funded by leading venture capital firms.
Newable: Helping over 20,000 businesses thrive annually with tailored financial products, advice, and flexible workspace solution
Show more
Investment focus
- Software, Health Care, Biotechnology
- Seed, Funding Round, Series A
- United Kingdom, United States
Portfolio highlights
- Delta g — Delta g Limited is a quantum technology and gravity gradiometry company. A spin-out from the University of Birmingham our technology has applications in industries as varied as civil engineering, infrastructure, defence, rail, navigation and resource exploration. Experts from science, engineering an
- Weldfast — Weldfast is a manufacturer and supplier of welding consumables, abrasives, chemicals, premium gas equipment, and safety products.
- EarSwitch — Empowering new ways to control and connect with the world through in-ear biometric switch and sensor technology
AlbionVC supports visionary founders and technologies with long-term capital and scale-up know-how. Founded in 1996, it was amongst the first to back leading global success stories such as Booking.com, Egress, Quantexa and Oviva. With £1bn in AUM and over 100 exits successfully realised, it funds venture breakthroughs that drive real outcomes forfounders, investors and society. AlbionVC is the technology investment arm of Albion Capital Group, which is authorised and regulated by the Financial Conduct Authority. For more information please visit: https://albion.vc/
Show more
Investment focus
- Software, Information Technology, Health Care
- Series A, Funding Round, Seed
- United Kingdom, United States, France
Portfolio highlights
- Kohort — How many users will your mobile game acquire, and how much more will they pour into your virtual economy? Try Ramp to find out.
- OpenTrade — OpenTrade providers web3 treasurers, institutions, and accredited investors access to on-chain structured financial products backed by investment grade RWAs.
- Latent Technology — Latent Technology builds the next-generation animation technology for virtual worlds.
IP Group's core business is the creation of value for its shareholders and partners through the commercialisation of intellectual property originating from research intensive institutions. Their strength lies in managing this process from finding suitable intellectual property to commercialise to either helping develop businesses and createvalue out of them, or identifying and establishing appropriate commercial partnerships to do so. IP Group's extensive expertise in this area combined with its inside knowledge of both industry and finance have enabled the group to create a formidable track record of consistently delivering excellent results for their companies, for their partners and for their shareholders.
Show more
Investment focus
- Health Care, Biotechnology, Information Technology
- Seed, Series A, Funding Round
- United Kingdom, United States, Australia
Portfolio highlights
- Lumai — Lumai delivers fully optical computing for a quicker, smarter and more sustainable world. Lumai power the revolution of fully optical computing by working at the nexus of photonics and machine learning.
- Alimetry — Alimetry is a health technology startup based in Auckland, New Zealand, developing breakthrough solutions for diagnosing disorders of gastrointestinal (GI) function.
- Diffblue — Diffblue Cover uses next generation autonomous AI to automate unit testing so that Java development teams can build better applications faster
Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series A, Series B, Seed
- United States, United Kingdom, Switzerland
Portfolio highlights
- Biolinq — Introducing a revolutionary platform for metabolic health.
- ChEmpower — ChEmpower is an advanced materials company that develops chemically reactive, abrasive-free planarization pads to improve chip yields and sustainability in semiconductor manufacturing.
- Corvic AI — Corvic AI is pioneering a new era of Data-Centric AI Cognitive Infrastructure by transforming raw enterprise data into AI-ready intelligence.
Helping individuals and institutions invest in Venture Capital, Infrastructure and Media companies since 1999.
Show more
Investment focus
- Software, Health Care, Biotechnology
- Funding Round, Seed, Series A
- United Kingdom, United States, France
Portfolio highlights
- Egregious — Egregious is an advanced research & intelligence lab established to defend humans from AI and provides narrative intelligence solutions across the public and private sectors to protect organisations and online users from malign influence using AI-driven data acquisition, insights, and engagement.
- Arcube — We make sure all travellers, frequent and infrequent, make the most of travel loyalty programs, using our data-driven approach, airlines can understand their customers and provide hyper-personalised offerings to boost value and retention.Arcube uses a data-driven approach to make the most of airline loyalty programs for both frequent andinfrequent flyers. Our software allows airlines to understand their customers and provide hyper-personalised offerings to boost value and retention at no extra cost to the airline.
- FinCrime Dynamics — Our mission is to help make the world’s financial system safer through rapid deployment of effective AI for financial crime analytics, enabled by enriched synthetic data that captures the dynamics of fraud and money laundering and loads them into tailor-made scenarios that explore diverse threats that financial organisations are exposed to.Thisgoal has taken us to the forefront of Synthetic Data and Fincrime Analytics, and we are proud to have in our team people that have helped shape the state-of-the-art of these fields.Keywords: Finacial services, AML, Synthetic Data, Fintech, Machine learning, Big data, Simulation, Fraud Analytics, Compliance
Wellcome Trust is a medical research charity that funds research that aims to protect and improving human and animal health. It focuses on the fields of public engagement, investments, innovation, humanities, and social science.
It was founded in 1936 and headquartered in London, England.
Show more
Investment focus
- Biotechnology, Health Care, Pharmaceutical
- Grant, Series C, Funding Round
- United States, United Kingdom, Germany
Portfolio highlights
- RenBio — RenBio develops antibody-based therapeutic solutions for the treatment of cancer and inflammatory diseases. RenBio's proprietary MYO technology involves in the development of antibody therapeutic that helps in treating rare diseases, viral infections, autoimmune diseases, and more by using DNA blueprint and antibody factory.
- Vaxxas — Vaxxas develops and commercializes needle-free vaccine delivery system. Vaxxas was incorporated in 2011 and is based in Brisbane, Australia.
- Cultivarium — We develop molecular, hardware and software tools to accelerate the adoption of microbes for beneficial biotechnologies.
Praetura Ventures has been supporting entrepreneurs with more than money since 2011. Click to find out more about how we can help businesses and investors.
Show more
Investment focus
- Software, Information Technology, Health Care
- Funding Round, Seed, Series A
- United Kingdom, Ireland, Australia
Portfolio highlights
- Outmin — An automated hospitality accounting solution that monitors and manages your entire financial operation. Bookkeeping, tax, payroll, suppliers, and weekly reporting.
- OBT Live — LiveOps technology enables optimum audience engagement by delivering hyper personalised experiences to your customers. hello@obt.live.
- Atomik AM — Innovative chemistry, solutions-based engineering, and a solution-focused philosophy enable us to meet the goals and commercial requirements of manufacturers.
We bring bold ideas to life to change the world for good.
Show more
Investment focus
- Biotechnology, Medical Device, Medical
- Funding Round, Seed, Series A
- United Kingdom, United States
Portfolio highlights
- Citymart — Citymart powers cities to deliver services that work. Following best practices developed with leading cities around the world, Citymart connects cities and revolutionizes the way cities frame needs, complete procurements, and improve service delivery. Over 100 cities in 35 countries have adopted Citymart tools and methods to-date.
- Featurespace — Featurespace™ is the world leader in Enterprise Financial Crime prevention for fraud and Anti-Money Laundering. Featurespace invented Adaptive Behavioral Analytics and Automated Deep Behavioral Networks, both of which are available through the ARIC™ platform, a real-time machine learning software that risk scores events in more than 180 countriesto prevent fraud and financial crime.ARIC™ Risk Hub uses advanced, explainable anomaly detection to enable financial institutions to automatically identify risk, catch new fraud attacks and identify suspicious activity in real-time. More than 30 major global financial institutions are using ARIC to protect their business and their customers. Publicly announced customers include HSBC, TSYS, Worldpay, NatWest, Contis, Danske Bank, ClearBank, Akbank and Permanent TSB.
- Radio Physics Solutions — PASAR123 merupakan landasan utama bandar slot nomor 1 di indonesia memiliki fasilitas slot deposit pulsa tanpa potongan penarikan sangat mudah dan cepat.
Empirical Ventures supports innovative approaches to critical problems in the fields of biotechnology and life sciences.
Show more
Investment focus
- Medical, Biotechnology, Medical Device
- Seed, Funding Round, Pre-Seed
- United Kingdom
Portfolio highlights
- OSSTEC — OSSTEC is bringing advanced technology to the operating room with metal 3D printed bone healing implants. The orthopaedic implants emulate natural bone structure and address high failure rates of existing implants, keeping patients who suffer with osteoarthritis healthy, active and enjoying life.
- OutSee — We are well-versed in a variety of genomics, AI and cohort analysis techniques. We are also bioinformatics generalists and work with just about any ...
- EnsiliTech — EnsiliTech is a biotechnology start-up developing ensilication, a platform technology, to remove the need for refrigeration when transporting and storing vaccines and biologicals
Providence Investment Company
Show more
Investment focus
- Biotechnology, Biopharma, Medical
- Funding Round, Series B, Seed
- United Kingdom
Portfolio highlights
- evonetix — Spearheading a radical new approach to gene synthesis to improve access to high-quality, gene-length DNA. Redefine possible.
- DefiniGEN — Generate metabolic disease phenotypes in primary-like human cells using the best-in-class human iPSC differentiation platform. Find out more here!
- CellCentric — CellCentric’s primary programme targets a deubiquitinase (DUB) enzyme which is strongly associated with prostate cancer, a leading cause of mortality among men. The target modulates the androgen receptor pathway and can potentially combat the multiple resistance mechanisms seen with recently approved prostate cancer drugs such Xtandi and Zytiga.The programme also has potential clinical utility in non-small cell lung, breast and colon cancer.
SyndicateRoom is fintech company made up of data-scientists, investment professionals, software developers and marketers with one mission: to be an early investor in every British startup success story.To do this – and make fund investors money – we don’t try to spot the next Big Thing.Instead, we apply a data-driven model to portfolioconstruction; a repeatable process designed to maximise returns and minimise risk for fund investors. As such, we build startup portfolios that don’t attempt to predict the future; they work to stack the odds in investors’ favour.Our fund, Access EIS, aims to build investors a diversified portfolio of 50+ companies by co‑investing exclusively with some of the UK’s best-performing angel investors.
Show more
Investment focus
- Health Care, Software, Medical
- Seed, Equity Crowdfunding, Funding Round
- United Kingdom, United States, India
Portfolio highlights
- Roomix — Make your home your own with Roomix. Get custom made products from expert joiners along with installation instructions and on-hand support. Floor Beds, wall panelling, shelving, radiator covers and lots more.
- OVA — OVA is a reproductive health brand designed to support both men and women on their fertility journeys.
- Noggin HQ — The next generation of credit referencing is coming. Look busy.
Discover the UK's leading SEIS Fund, offering tax-efficient investments in innovative startups. Join thousands of savvy investors and raise capital for your business with SFC Capital.
Show more
Investment focus
- Software, Artificial Intelligence, Information Technology
- Pre-Seed, Seed, Funding Round
- United Kingdom, United States, Canada
Portfolio highlights
- Paapi — The truth-first ad measurement platform for D2C marketers tired of ad platform propaganda and wasted spend.
- TILKI — TILKI is an AI-powered game creation platform that democratizes video game development by enabling all creators to build immersive games without coding.
- Privasee — Privasee is a self-compliance tool that takes away the complexity of GDPR and makes it easy for SMEs to understand their data and mitigate its risks.
Mercia Asset Management provides equity and debt to UK businesses with growth ambition. We are your investment partners from scale-up to exit.
Show more
Investment focus
- Software, Information Technology, Manufacturing
- Funding Round, Series A, Seed
- United Kingdom, United States
Portfolio highlights
- Netacea — Netacea takes a smarter approach to bot management. Intent Analytics™ powered by machine learning quickly and accurately distinguishes bots from humans to protect websites, mobile apps and APIs from automated threats while prioritising genuine users. Actionable intelligence with data-rich visualisations empowers you to make informed decisions aboutyour traffic. The Netacea approach offers incredible speed, accuracy and transparency, solving the growing problem of credential stuffing and account takeover at scale. The technology is designed to complement existing controls such as WAF rulesets, rate limiting and threat databases to provide a deep analysis of all website visitors, actionable intelligence and real-time threat.The Netacea approach continuously monitors your web traffic to pinpoint the difference in automated bot activity vs genuine visitors, keeping you ahead of evolving bot threats. Choose to automatically block, redirect or challenge automated attacks in real-time, or receive alerts notifying you of potential threats. With access to rich dashboards and data, you can easily identify and stop account takeover attempts early in the attack chain.Learn more at www.netacea.com
- Semble — The integrated clinical system for managing your patients' medical data and admin tasks.
- Locate Bio — Locate Bio is a regenerative medicine development company focused on orthobiologics. Locate Bio exists to help surgeons improve the lives of people with debilitating spinal conditions. We are curious about what is possible, but ground all our work in robust scientific evidence. We relentlessly pursue high-value opportunities with clear unmetclinical needs.
Innovate UK is part of the UK Research and Innovation .
Show more
Investment focus
- Health Care, Biotechnology, Software
- Grant, Seed, Pre-Seed
- United Kingdom, United States, Canada
Portfolio highlights
- Hormona — Understand your hormones with the Hormona app. Monitor hormone levels, track symptoms, forecast cycles, and access personalized wellness tips for a balanced life.
- Koolboks — Koolboks: solar-powered, financially accessible fridges with an integrated pay-as-you-go platform dedicated to making cooling accessible to all of Sub-Saharan Africa. Get a Koolboks refrigerator for as little as 25k Naira down payment today!
- CrossSense — CrossSense is a pioneering wearable AR solution designed to enhance autonomy for individuals with mild dementia, improving quality of life.
At Calculus Capital they are specialists in creating and managing tax efficient private equity funds for the individual. Funds that are ideal for today's market - offering generous tax benefits, and significant growth potential within a sensible risk profile.They look to make £2-5 million investments in established companies with provenmanagement teams and a successful product or service. Their entrepreneurial flair, combined with their experience and sound commercial judgement has resulted in a diversified investment portfolio and an impressive track record. In June 2013 Calculus Capital was top ranked in the prestigious Martin Churchill Tax Efficient Review for the 6th year in a row. The Government has recently shown its support for EIS funds, by maintaining the five generous tax benefits and widening the scope of EIS investments. These changes benefit Calculus Capital's rigorous and proven strategy. As a result they are experiencing their strongest pipeline of prospective investments yet.
Show more
Investment focus
- Biotechnology, Software, Health Care
- Funding Round, Series A, Seed
- United Kingdom, United States, Ireland
Portfolio highlights
- Booked It — The all-in-one booking platform for Family Ticketing, booking, loyalty and marketing, in one powerful, modular solution. Book a Demo Give...
- EnsiliTech — EnsiliTech is a biotechnology start-up developing ensilication, a platform technology, to remove the need for refrigeration when transporting and storing vaccines and biologicals
- Laverock Therapeutics — Laverock Therapeutics is developing a gene silencing platform for the creation of programmable, allogeneic cell therapies.
We deploy early stage capital to fuel the growth of need-driven health technology companies.
Show more
Investment focus
- Health Care, Artificial Intelligence, Medical
- Seed, Pre-Seed, Series A
- United States, United Kingdom, Germany
Portfolio highlights
- CryoCloud — CryoCloud Accelerate your protein structure determination - Bring your cryo-EM data analysis to the next level by using our cloud-based image analysis workflow.
- EarlySight — EarlySight start-up company is founded in order to accelerate the development and to bring the technology to clinics.
- Magentiq Eye Ltd — AI assisted colonoscopy by MAGENTIQ EYE set a new standard of , recognized by the gastroenterology community for its superior performance.
Foresight Group is a listed infrastructure and private equity investment manager which has been managing funds on behalf of institutions and retail clients for more than 35 years. Foresight has over £7.2 billion of assets under management across a number of funds on behalf of some of the world’s largest institutional investors, family offices,private and high net-worth individuals and retail investors. Foresight's investment strategies are underpinned by a strong environmental, social & governance (“ESG”) focus, which increasingly meets the demands of today’s investors and ensures we are consistently working towards creating a sustainable legacy for future generations.
Show more
Investment focus
- Software, Manufacturing, Health Care
- Funding Round, Private Equity, Seed
- United Kingdom, United States, Ireland
Portfolio highlights
- Ad Signal — Ad Signal provides a SaaS platform that leverages signal-based marketing to help advertisers deliver relevant messages to customers without relying on third-party cookies. The company offers tools for deduplicating and annotating content libraries, which can save businesses money. Ad Signal's technology focuses on sustainable fingerprinting toenhance marketing efficiency and effectiveness.
- Spaceflux — As satellites become increasingly vital, Spaceflux tackles the growing challenges of orbital congestion and debris that put them at risk. Thanks to our proprietary global network of optical sensors, we provide data-driven space situational awareness services from LEO to Cislunar.
- Zayndu — Boosting crop yield through non-toxic plasma treatment installed on grower's sites
Mercia Asset Management provides equity and debt to UK businesses with growth ambition. We are your investment partners from scale-up to exit.
Show more
Investment focus
- Health Care, Biotechnology, Software
- Funding Round, Seed, Series A
- United Kingdom, United States
Portfolio highlights
- Flabba — Flabba offers video communications with integrated functionality and workflows that help companies solve practical, operational & commercial problems. They also reduce the carbon footprint of recruitment and save companies time and money. Providing video-enabled, business apps with innovative features that boost productivity, visibility, andprofitability.
- The One Point — The One Point is a single point of contact for managed technology offering IT support, Business Mobiles, VoIP, Connectivity, Print and Digital Services.
- Axis Spine Technologies — Axis Spine Technologies is building an expert team to develop highly differentiated products that provide meaningful improvements in patient care.
Crista Galli Ventures invests in ambitious European healthtech companies at Seed and Series A. Our deep medical expertise, powerful network and agile approach enable founders to build important, world-class healthcare businesses.
Show more
Investment focus
- Health Care, Wellness, Medical
- Seed, Pre-Seed, Series A
- United Kingdom, United States, Sweden
Portfolio highlights
- Jude — Science-backed food supplement that makes you feel empowered, not embarrassed.
- Vitrue Health — At Vitrue Health, our mission is to reduce or eliminate the impact that musculoskeletal health issues have on over 40% of the population using cutting edge technology. We believe that the foundation of successful outcomes in musculoskeletal health, at every stage of the pathway, is accurate assessment. Whether it's a desk worker with early stages of neck pain or a patient having a total knee replacement, Vitrue's technology can help.
- Collective Minds Radiology — Collective Minds develops and delivers a cloud-based collaboration platform for healthcare and research with access to data, human and digital expertise.
xford Investment Consultants LLP ("OIC") advises Thompson Taraz, the Investment Manager of Oxford Technology and Innovations EIS Fund ("OTIF"). OIC is an Appointed Representative of Stoneware Captial LLP, which is authorized and regulated by the Financial Conduct Authority in the United Kingdom.The focus of OIC research ison University of Oxford spin out companies.Over the last fifteen years Oxford has produced a string of world-class spin-out companies. It is our belief that the next generation of world-class Oxford businesses is just waiting to be discovered.
Show more
Investment focus
- Health Care, Software, Biotechnology
- Series A, Seed, Funding Round
- United Kingdom
Portfolio highlights
- Diffblue — Diffblue Cover uses next generation autonomous AI to automate unit testing so that Java development teams can build better applications faster
- Caristo Diagnostics — Our AI powered CaRi-Heart technology uncovers coronary inflammation, atherosclerosis, and plaque progression on cardiac CT. Learn more about our award-winning technology
- Oxford Quantum Circuits — We deliver Enterprise ready quantum solutions that are hybrid workload ready
BGF is the most active equity investor in the UK and Ireland, providing long-term, minority investment to growing companies.
Show more
Investment focus
- Software, Information Technology, Health Care
- Funding Round, Series A, Private Equity
- United Kingdom, Ireland, United States
Portfolio highlights
- Xampla — Xampla's natural plant polymer technology is the innovative technology powering materials to change the world with plastic-free replacements and more.
- CWC Group — CWC Group's objective is to deliver superior care in our family-oriented homes.
- Enhanc3D Genomics — Enhanc3D Genomics is a spinout company from Babraham Institute.
Eos invests in, & commercialises, science & technology, from local seed-stage to global scale, with a focus on improving lives.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Seed, Funding Round, Series A
- United Kingdom, Ireland, United States
Portfolio highlights
- EnsiliTech — EnsiliTech is a biotechnology start-up developing ensilication, a platform technology, to remove the need for refrigeration when transporting and storing vaccines and biologicals
- Biotangents — Biotangents develops veterinary diagnostic tests to detect infectious diseases in livestock (bovine viral diarrhoea (BVD), mastitis, bovine respiratory disease (BRD), brucellosis) using our highly adaptable molecular diagnostic technology, Moduleic Sensing.
- Concinnity Genetics — Concinnity designs unique RNA-based gene control systems that enable the precise control of gene therapies to improve safety.
We provide venture capital investment for the people, ideas and industries that will change the world. Learn about what we do and the kind of founders we back.
Show more
Investment focus
- Software, Health Care, Information Technology
- Series A, Seed, Series B
- United Kingdom, United States, Germany
Portfolio highlights
- CRED — Compare millions of commercial data points and uncover unique and personalised opportunities for your brand.
- Healsgood Ai LTD — Discover how HealsGood is revolutionising healthcare with AI-powered workforce solutions. Explore our expertise in clinical insourcing, staff bank management, and secure data-driven technology.
- Perci Health — Connecting cancer patients with expert practitioners. On-demand, affordable appointments. Get personalised support and a tailored care plan today.
Brilliant Ideas. Brilliant People. Brilliant Minds.
Show more
Investment focus
- Biotechnology, Health Care, Software
- Seed, Funding Round, Convertible Note
- United Kingdom, United States, Canada
Portfolio highlights
- SugaROx — Discover SugaROx, pioneers in biostimulant technology. Boosting crop resilience, and yield with their science-backed agricultural solutions.
- Ikarovec — Ikarovec is developing novel gene therapies to treat major ophthalmic indications.
- Inicio AI — A specialist Income & Expenditure trained virtual agent delivering improved CX and robust results
Epidarex Capital invests in early-stage, high growth life science and health technology companies in under-ventured markets. Its international team is led by Sinclair Dunlop, Kyp Sirinakis and Liz Roper. With offices in the United States and United Kingdom Epidarex Capital’s investors represent a cross-section of leading universities, internationalcorporations, development agencies and financial institutions. Epidarex was created to meet the need for more sector-specific financial backing for young companies, including spin-outs from leading research universities.
Show more
Investment focus
- Biotechnology, Therapeutics, Health Care
- Series A, Seed, Series B
- United Kingdom, United States, Germany
Portfolio highlights
- Theolytics — Theolytics is a biotechnology company harnessing viruses to combat cancer. A step-change in the oncolytic viral therapy field, our phenotypic screening Platform enables the discovery and development of efficacious, targeted candidates suitable for intravenous delivery and optimised for a chosen patient population. In addition to advancing aninternal Pipeline of programs spanning both solid and liquid tumours, we are establishing select strategic partnerships to expand and accelerate pipeline development.
- Ryme Medical — Ryme Medical is a device company developing a novel catheter-based treatment for COPD
- Curve Therapeutics — Curve has developed an innovative screening platform that is transforming the discovery of first-in-class therapeutics. The platform allows functional screening of diverse, genetically encoded Microcycle™ libraries against a broad range of disease-associated targets that are present in their native conformation inside a mammalian cell. Curve isdeploying this platform to build a pipeline of novel cancer drugs.
A new model for Venture Capital where every founder we back becomes a co-owner of the fund
Show more
Investment focus
- Software, Biotechnology, Information Technology
- Seed, Series A, Series B
- United Kingdom, United States, Germany
Portfolio highlights
- Cakewalk — Cakewalk enables IT & Security teams to monitor all SaaS apps used by their employees, run compliant access flows, securely on- and offboard people, and be IT audit-ready.
- Latent Labs — Latent Labs is making biology programmable to transform health and sustainability for the benefit of all.We are a frontier AI lab building foundational models that capture the fundamentals of biology. We empower partners with breakthrough generative AI to gain unprecedented control over molecular biology, creating new antibodies, optimizingexisting enzymes, and advancing genetic engineering.Contact us to work with us today.
- Sohar Health — Streamline patient intake and boost revenue with Sohar's real-time insurance verification and eligibility solutions. Automate workflows, reduce claim denials, and improve conversion rates with accurate, fast, and reliable tools. Book a demo today to transform your patient onboarding process.
Working with academic entrepreneurs, QUBIS Ltd has grown a portfolio of shareholdings in viable companies over 27 years that have succeeded on an international level.
Show more
Investment focus
- Health Care, Medical, Biotechnology
- Seed, Funding Round, Pre-Seed
- United Kingdom, United States
Portfolio highlights
- RETìníZE — RETìníZE is an AR, VR, multi-screen installations, and software development.
- StimOxyGen — StimOxyGen specializes in developing innovative, pH-responsive nanoparticles designed to generate oxygen in hypoxic tumors. This technology aims to enhance the effectiveness of cancer treatments such as radiotherapy and chemotherapy by addressing tumor hypoxia, a significant clinical challenge. F
- AMPLY Discovery — AMPLY Discovery is to develop new biological molecules for anti-infective health and nutrition applications in animal and human health.
The wholly owned knowledge and technology venturing company of Ulster University.
Show more
Investment focus
- Health Care, iOS, Sports
- Seed, Series A, Pre-Seed
- United Kingdom, Ireland
Portfolio highlights
- Axial3D — Leading the way with the latest 3D imaging, models, and devices
- RETìníZE — RETìníZE is an AR, VR, multi-screen installations, and software development.
- NeuroCONCISE — Innovative and stylish wearable neurotechnology for brainwave measurement and analysis. Neurotechnology, Biotechnology, Brain-Computer Interfacing, BCI, Flex EEG, EEG, Clinical Trials, Clinical Assessment Tools, Machine Learning, Prolonged Disorders of Consciousness Research, Research
Syncona is a FTSE250 company focused on founding, building and funding healthcare companies to deliver transformational treatments to patients in areas of high unmet need.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Series B, Seed
- United Kingdom, United States, Switzerland
Portfolio highlights
- Apini Therapeutics — Apini is a creating novel small chemical two most prevalent types of inflammatory bowel disease.
- Purespring Therapeutics — Purespring Therapeutics is an AAV gene therapy company focused on the kidney globally.
- Resolution Therapeutics — Resolution Therapeutics is a biopharmaceutical company developing macrophage cell therapy to treat chronic diseases.
Looking for an IoT investor for your start up or early stage company? Tern PLC is a venture capitalist working alongside ambitious entrepreneurs in the Internet of Things (IoT) space to deliver strategic IoT investment to grow your company.
Show more
Investment focus
- Software, Information Technology, Artificial Intelligence
- Funding Round, Seed, Series A
- United Kingdom, United States
Portfolio highlights
- Konektio — Konektio is a dedicated M2M and IoT company which uses the best technology to deliver performance and solutions quickly and cost effectively. When you enquire we will need to visit you to discuss how to maximise the Konektio benefits for your particular business, whether OEM or End User, and also the type of devices (things) that you wish toconnect to. Our experience will help you to get the most out of any investment.
- FundamentalVR — A strategic partner helping med-device leaders solve the Competency @ Scale Gap todrive commercial success.
- Talking Medicines — Discover AI-powered HCP and Patient Intelligence for Healthcare Marketing with Talking Medicines. Drug-GPT delivers actionable insights, revolutionizing AI in Pharma Marketing with advanced HCP Analytics and Patient Analytics.
Founded as an investment firm focusing on the most promising startups, we have evolved into a unique set of private market funds investing globally in equity and debt across complementary sectors and stages. We fuse traditional values with a contemporary approach and balance exacting processes with the agility to capture commercial opportunity andcompelling investment returns. Our continuous search for new opportunities has led us to create a balanced collection of complementary funds and relationships.
Show more
Investment focus
- Software, Health Care, Financial Services
- Seed, Series A, Secondary Market
- United Kingdom, Germany, United States
Portfolio highlights
- HeadBox — HeadBox is a new online marketplace for creative, inspiring and offsite spaces. They are the first platform in the UK to directly link their Guests (corporate and SME bookers) to their Hosts (owners of those creative, inspiring spaces) allowing you to instantly search, book and pay in an easy and seamless way saving time and hassle when planning aSpace experience.
- Merit Incentives — Seamless, API-driven solutions connecting you to a global network of 7,000+ brands, enabling real-time, instant gratification across 155+ countries.
- Bumper — Split the cost of your car repairs and servicing into manageable monthly instalments with 0% interest. Fix it. Split it. Sorted.
Southern Angel Investors Club, combining Surrey investors Club & Angels 5K, are entrepreneurs who understand what new businesses need.
Show more
Investment focus
- Biotechnology, Software, Medical
- Seed, Funding Round, Angel
- United Kingdom
Portfolio highlights
- Celixir — Celixir is a developer of regenerative medicines created to change the lives of patients in need. The company's medicines consists of iMP cells, platelet lysate and PML cells to treat patients with ischaemic heart disease, injured tendons near the surface of the skin and mild to moderate heart failure respectively, enabling medical researchersto discover breakthrough medicines that aim to change the standard of medical care for patients.
- Novastone Media — Novastone enables instant chat across mobile and web to move customer conversations from email. Novastone’s white label chat solutions, built by financial industry experts, deliver on all these requirements, seamlessly moving organisations’ most valuable relationships from the inbox into a chat conversation.
- Geektastic — Geektastic guarantees hiring teams only meet high calibre candidates. Our technical code challenges quickly identify the most talented software engineers.
We invest venture capital in to globally ambitious companies which have the potential to deliver a significant return to our investors
Show more
Investment focus
- Health Care, Biotechnology, Manufacturing
- Seed, Funding Round, Series A
- United Kingdom, United States
Portfolio highlights
- novosound — Novosound is an award winning Scottish sensors company utilising thin-film processes to eliminate conventional limitations in ultrasound sensors.
- Chromacity — Chromacity manufacture the next generation of ultrafast lasers. Discover our fixed wavelength femtosecond lasers and picosecond OPOs.
- Biotangents — Biotangents develops veterinary diagnostic tests to detect infectious diseases in livestock (bovine viral diarrhoea (BVD), mastitis, bovine respiratory disease (BRD), brucellosis) using our highly adaptable molecular diagnostic technology, Moduleic Sensing.
SIS Ventures has been created with the overall aim of supporting and growing high impact organisations through access to mission-aligned investment. SIS Ventures has a goal of becoming the go to investor and partner for social entrepreneurs. The fund will offer conventional financial returns alongside social and/or environmental returns byinvesting either equity or debt into purpose driven companies.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Seed, Series A, Funding Round
- United Kingdom
Portfolio highlights
- MiAlgae — MiAlgae is a new-age microalgal production company that aims to revolutionize the £340 billion global livestock feed industry by producing microalgal products – through the remediation of wastewater – as nutrient supplements for fishmeal in livestock feeds. Their microalgal products are high in omegas and proteins, both of which are required forthe production of many livestock feeds, especially in the aquaculture sector.Their production methodology uses circular economy to reduce the operating costs involved in the production of microalgae and as such allows them to compete with other supplements currently on the market.
- Metacarpal — Metacarpal design upper-limb prosthetics without compromise. We aim to make the most robust, functional hand prosthesis that people love wearing because it works so effectively and looks so beautiful. Be proud to show your artificial side!
- Solasta Bio — Solasta Bio develops environment-friendly products that meet a global need for new and effective crop protection.
Investors by industry
Google
Marketplace
Hardware
Energy
Proptech
Health Care
Biotech
Artificial intelligence
Climate
Consumer
Community
Impact
Gaming
FinTech
EdTech
Sustainability
Venture Capital
Big Data
Web3
B2B
Financial Services
Finance
Infrastructure
Education
Photography
Payments
Food and Beverage
Video Games
Organic Food
Retail
Beauty
Publishing
Clean Energy
Real Estate
Manufacturing
Art
Music
Android
Internet
Enterprise Software
eSports
Franchise
Sports
Construction
Digital Media
Email
Medical
Social Network
Wellness
Social Media
Mobile
Legal
Local
Recruiting
Cannabis
Platforms
Fitness
Travel
Mobile Advertising
Biotechnology
Hospitality
Social
Automotive
Crowdfunding
Wine And Spirits
Medical Device
CleanTech
Transportation
Mobile Apps
InsurTech
Enterprise
LGBT
Fashion
Oil and Gas
Life Science
Theatre
Film
Non Profit
Renewable Energy
SaaS
Sporting Goods
Restaurants
Social Impact
Software
Celebrity
Cryptocurrency
Machine Learning
Agriculture (agtech)
Media (entertainment)
Facebook
Blockchain
Investors by country
United Kingdom
Canada
South Korea
Ireland
United States
New Zealand
India
Germany
Australia
Armenia
South Africa
Spain
Japan
Africa
China
Sri Lanka
Singapore
Qatar
Asia
Indonesia
Vietnam
Oceania
LATAM
Middle East
Europe
Saudi Arabia
Brazil
Bulgaria
Belize
Bahrain
Croatia
Georgia
Belarus
Hungary
France
Ghana
Ethiopia
Gibraltar
Liechtenstein
Liberia
Lebanon
Mauritius
Peru
Norway
Israel
Chile
Malaysia
Mexico
Nicaragua
Egypt
Jersey
Panama
Finland
Morocco
Costa Rica
Mali
Lithuania
Italy
Greece
Philippines
Kuwait
Malta
Myanmar
Sierra Leone
El Salvador
Barbados
Uganda
Belgium
Venezuela
Sweden
Slovenia
Poland
Uruguay
Ukraine
Estonia
Tajikistan
Puerto Rico
Portugal
Tunisia
Taiwan
Tanzania
Turkey
San Marino
Senegal
Togo
Uzbekistan
Serbia
Bermuda
Russian Federation
Zambia
Czech Republic
Rwanda
Zimbabwe
Thailand
Dominican Republic
Denmark
Azerbaijan
Iceland
Nigeria
Bahamas
Namibia
Iraq
United Arab Emirates
Jamaica
Algeria
Honduras
Hong Kong
Isle of Man
Bolivia
Luxembourg
Ecuador
Faroe Islands
Grenada
Pakistan
Albania
Jordan
Romania
Bangladesh
Argentina
Kenya
Kazakhstan
Cayman Islands
Cambodia
Oman
Latvia
Cyprus
Guatemala
Austria
Switzerland
Cameroon
Colombia
Seychelles
Marshall Islands
VC (Venture Capital) Funds in United Kingdom by industry
Transportation
Enterprise
FinTech
Biotech
Health Care
EdTech
Climate
Impact
Proptech
Marketplace
SaaS
Artificial intelligence
Community
Hardware
Gaming
Restaurants
Crowdfunding
Film
Real Estate
Venture Capital
Fashion
Web3
Financial Services
Cryptocurrency
Education
Finance
Payments
Medical Device
Food and Beverage
Organic Food
Medical
Wine And Spirits
Video Games
Internet
Social Media
Social Network
Art
Manufacturing
Digital Media
Music
Android
Blockchain
Software
Legal
Construction
Local
Enterprise Software
eSports
Sports
Fitness
Automotive
Travel
Hospitality
Recruiting
Cannabis
Mobile
Biotechnology
Platforms
Mobile Advertising
Mobile Apps
Retail
Social
Beauty
B2B
Sporting Goods
Photography
Publishing
Big Data
Renewable Energy
Clean Energy
Oil and Gas
Email
Infrastructure
Energy
Consumer
Wellness
Theatre
Life Science
Franchise
Agriculture (agtech)
Media (entertainment)
Non Profit
Machine Learning
CleanTech
InsurTech
Social Impact
Facebook
Sustainability